1. Home
  2. SUNS vs THRD Comparison

SUNS vs THRD Comparison

Compare SUNS & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUNS
  • THRD
  • Stock Information
  • Founded
  • SUNS 2023
  • THRD 2019
  • Country
  • SUNS United States
  • THRD United States
  • Employees
  • SUNS N/A
  • THRD N/A
  • Industry
  • SUNS Real Estate Investment Trusts
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SUNS Real Estate
  • THRD Health Care
  • Exchange
  • SUNS Nasdaq
  • THRD Nasdaq
  • Market Cap
  • SUNS 148.2M
  • THRD 164.2M
  • IPO Year
  • SUNS N/A
  • THRD 2022
  • Fundamental
  • Price
  • SUNS $10.63
  • THRD $5.15
  • Analyst Decision
  • SUNS Strong Buy
  • THRD Hold
  • Analyst Count
  • SUNS 3
  • THRD 3
  • Target Price
  • SUNS $13.42
  • THRD $5.00
  • AVG Volume (30 Days)
  • SUNS 110.8K
  • THRD 1.1M
  • Earning Date
  • SUNS 05-07-2025
  • THRD 05-08-2025
  • Dividend Yield
  • SUNS 8.79%
  • THRD N/A
  • EPS Growth
  • SUNS N/A
  • THRD N/A
  • EPS
  • SUNS 1.02
  • THRD N/A
  • Revenue
  • SUNS $13,066,680.00
  • THRD N/A
  • Revenue This Year
  • SUNS $113.67
  • THRD N/A
  • Revenue Next Year
  • SUNS $35.05
  • THRD N/A
  • P/E Ratio
  • SUNS $10.38
  • THRD N/A
  • Revenue Growth
  • SUNS 1342.10
  • THRD N/A
  • 52 Week Low
  • SUNS $7.80
  • THRD $3.18
  • 52 Week High
  • SUNS $15.74
  • THRD $16.94
  • Technical
  • Relative Strength Index (RSI)
  • SUNS N/A
  • THRD 76.76
  • Support Level
  • SUNS N/A
  • THRD $5.11
  • Resistance Level
  • SUNS N/A
  • THRD $5.25
  • Average True Range (ATR)
  • SUNS 0.00
  • THRD 0.05
  • MACD
  • SUNS 0.00
  • THRD -0.04
  • Stochastic Oscillator
  • SUNS 0.00
  • THRD 27.54

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: